Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Ultrasound Med Biol. 2018 Dec 21;45(2):513–525. doi: 10.1016/j.ultrasmedbio.2018.10.003

Figure 4. Placement of the Reservoir Patch (A) and Active Patch (B) on a subject.

Figure 4.

(A) Following active treatment (30 minutes), the passive drug-containing Reservoir Patch remained on the Subject for a twelve-hour treatment period. (B) Ultrasound patch (Active Patch) lying on top of the Reservoir Patch, following addition of reconstituted drug. The Active Patch was aligned with the reservoir using a rounded metal alignment band held during active treatment using medical adhesive bandage. The Control Sites for TEWL measurements are represented with a circle, and the general treatment areas (Patch Site) are represented with rectangles.